#SCANDION - Twitter Hashtag

over 2 years ago

CEO Francois Martelet explains the positive results from the CORIST part 3 trial announced yesterday. The results will be presented at an Investor Event on February 5 at 14:00 CET. #Scandion #SCOL #oncology #cancer

0

9

1

0

559

Scandion Oncology @Scandion

over 2 years ago

In November we presented impressive Overall Survival (OS) data from our CORIST trial. Watch CEO Francois Martelet explain the importance of OS in cancer drug development in the video below. #Scandion #SCOL #oncology #cancer

0

7

0

458

Scandion Oncology @Scandion

almost 3 years ago

Scandion has identified a potentially effective treatment of gastric cancer. Watch CEO Francois Martelet explain below and read more in our press release: https://t.co/sqbkq4668y #Scandion #SCOL #oncology #cancer

0

17

1

0

689

Scandion Oncology @Scandion

almost 3 years ago

This morning we published our Interim Report for the third quarter of 2023 in which we maintained our strong operational momentum. https://t.co/AX4Jhmz9lQ #Scandion #SCOL #oncology #cancer

0

5

1

0

403

Scandion Oncology @Scandion

almost 3 years ago

We are looking forward to having clinical safety data from our PANTAX trial presented on a poster at the European Society for Medical Oncology (ESMO) Congress 2023 starting Friday in Madrid. Read more: https://t.co/si8xUOE9jD #Scandion #SCOL #oncology #cancer

0

5

1

0

536

Scandion Oncology @Scandion

almost 3 years ago

We are looking forward to the LSX Nordic congress in Copenhagen this week, where CEO Francois Martelet will participate in a panel discussion. #Scandion #SCOL #oncology#cancer

Scandion's tweet photo. We are looking forward to the LSX Nordic congress in Copenhagen this week, where CEO Francois Martelet will participate in a panel discussion.

#Scandion #SCOL #oncology#cancer https://t.co/ZhQlyrB5tg

0

6

0

513

Scandion Oncology @Scandion

about 3 years ago

We are pleased to announce the appointment of Lars Damstrup, MD, PhD, as Chief Medical Officer (CMO). Lars will report to CEO Francois Martelet as a member of Scandion’s Executive Management. Read more: https://t.co/bGsQetWIJm #Scandion #SCOL #oncology #cancer

0

3

2

0

503

Scandion Oncology @Scandion

about 3 years ago

We are pleased to announce that safety data from the PANTAX phase 1b trial will be presented at the European Society for Medical Oncology (ESMO) Congress 2023. Read more: https://t.co/zabUZzqFum #Scandion #SCOL #oncology #cancer

0

8

1

0

475

Scandion Oncology @Scandion

about 3 years ago

Our Q2 2023 interim report will be published on Wednesday August 23 with Executive Management hosting a webcast and conference call the same day at 10:00 CET. Details on how to access the event can be obtained here: https://t.co/YKMe33LTcJ #Scandion #SCOL #oncology #cancer

0

2

1

0

397

Scandion Oncology @Scandion

about 3 years ago

The European Patent Office (EPO) intends to grant the Composition-of-Matter patent for Scandion’s lead compound SCO-101. This decision follows the positive opinion issued by the EPO in January 2023. Read more: https://t.co/HPqu06JEz1 #Scandion #SCOL #oncology #cancer

0

6

0

361

Scandion Oncology @Scandion

over 3 years ago

We just published our Interim Report for the first quarter of 2023. In the quarter we continued to execute our plans, progressed our clinical trials and took the first steps of our strategy to enter leukemia. https://t.co/tbfAG4cr2T #Scandion #SCOL #oncology #cancer

0

2

1

0

425

Scandion Oncology @Scandion

over 3 years ago

We have today carried through our Annual General Meeting and results are now available: Read more: https://t.co/0EBDTp9CQc #Scandion #SCOL #oncology #cancer

0

2

0

239

Scandion Oncology @Scandion

over 3 years ago

We are looking forward to participating in the Swiss Biotech Day conference 2023 in Basel on Tuesday with a presentation by Mads Aaboe Jensen, VP of Business Development and Innovation. https://t.co/vSGwsmvsfw #Scandion #SCOL #oncology#cancer

Scandion's tweet photo. We are looking forward to participating in the Swiss Biotech Day conference 2023 in Basel on Tuesday with a presentation by Mads Aaboe Jensen, VP of Business Development and Innovation.

https://t.co/vSGwsmvsfw

#Scandion #SCOL #oncology#cancer https://t.co/VUDFItuR0b

0

4

0

331

Scandion Oncology @Scandion

over 3 years ago

Our CEO, Francois Martelet, will tomorrow give the keynote address at the Freeths Annual Life Science Summit in London themed “Reimagining the future of Life Sciences”. Read more: https://t.co/3CC40UdKa7 #Scandion #SCOL #oncology #cancer

Scandion's tweet photo. Our CEO, Francois Martelet, will tomorrow give the keynote address at the Freeths Annual Life Science Summit in London themed “Reimagining the future of Life Sciences”.

Read more: https://t.co/3CC40UdKa7

#Scandion #SCOL #oncology #cancer https://t.co/hw6r9gof7B

0

5

0

525

Scandion Oncology @Scandion

over 3 years ago

We have successfully completed the dose finding in the PANTAX phase Ib trial, which studies our lead compound SCO-101 as combination treatment of pancreatic cancer. Read more: https://t.co/wGHjj4Yq9g #Scandion #SCOL #oncology #cancer

0

3

0

418

Scandion Oncology @Scandion

over 3 years ago

We are excited to be on stage at the Swiss Nordic Bio conference in Zurich on Thursday. https://t.co/xcZjaTVko0 #Scandion #SCOL #oncology #cancer

1

2

0

339

Scandion Oncology @Scandion

over 3 years ago

We will publish our 2022 Annual Report on Tuesday March 28, 2023, with Executive Management hosting a webcast and conference call the same day at 10:00 CET. Details on how to access to the event can be obtained here: https://t.co/5TVznsr8zG #Scandion #SCOL #oncology #cancer

0

2

0

298

Scandion Oncology @Scandion

over 3 years ago

Introducing Francois. In this video you can meet Francois Martelet, CEO of Scandion since January, and hear about his background and ambitions for Scandion. #Scandion #SCOL #oncology #cancer

0

6

0

547

Scandion Oncology @Scandion

over 3 years ago

We have received a favorable patentability opinion from the European Patent Office (EPO) on an international patent application aiming to further enhance the patent protection of our lead compound SCO-101. Read more: https://t.co/wjszd6UdNc #Scandion #SCOL #oncology #cancer

5

11

0

466

Scandion Oncology @Scandion

over 3 years ago

Jan Stenvang, Ph.D., has been appointed Chief Scientific Officer and member of Executive Management at Scandion. Jan is co-founder of the company and has more than 20 years of experience in cancer research. https://t.co/oMyLzOZ2Nu #Scandion #SCOL #oncology #cancer

1

8

0

623

Top Tweets for #SCANDION

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users